WHO_RAISED_WHAT
roundscompaniessectorsmultiplesinvestorspeoplefundsgraphgossip
>/
browsesector narrativesindustriescountriesstagesstackmapAI supply chainstats
machinesapillms.txtchanges feed
aboutprovenanceobjectionschanges
CC-BY-4.0

companies / antaresrx-com

Antares Therapeutics

Stock summary

Generated 2026-11-09 UTC · publication cutoff 2026-11-09

Insufficient cited evidence for a two-sentence summary.

Investors and explicit leads
  • Antares Therapeutics was listed in Atlas Venture's portfolio, recorded 2026-09-30.

    Evidence · 1 citation
    • Atlas Venture · retrieved 2026-09-30

verified=2026-10-03   json

total_raised177,000,000177.0M○
founded2025
hqBoston USA
industryunknown
stageseries-a

Precision oncology biotech developing small-molecule drugs for cancer and other serious diseases, spun out of Lilly's Scorpion Therapeutics acquisition with $177M funding. Targets pharma partners and patients with previously undruggable cancer targets. First clinical trial expected in 2026 from an integrated medicinal chemistry and predictive science platform.

acquisitions n=0

No cited completed company acquisition recorded.

traction n=0

Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.

No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.

valuations n=0

No cited valuation with an explicit basis is recorded.

revenue multiples n=0

Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.

No qualifying pair recorded.

rounds n=1

datetypeamountleadsrc
2025-06-01series-a177,000,000177.0Mnull○
2025-06-01 series-a177,000,000177.0M
null   ○

people n=0

No person is documented for this company.

investors n=1

investorsrc
Atlas Venture○
Atlas Venture○
investor

stack

Nginx, Akismet, Google Analytics, Google Tag Manager, DoubleClick Floodlight, Contact Form 7 6.1.6, WordPress, WordPress Block Editor, WP Rocket 3.21.3, wp.cloud, PHP, MySQL

provenance

factstatussrc
Series A, $177.0Mattributed○
Investor Atlas VenturesourcedWEB
existencesourcedWEB
descriptionself-reportedWEB
Series A, $177.0M○
attributed
Investor Atlas VentureWEB
sourced
existenceWEB
sourced
descriptionWEB
self-reported

change_history

datefactchangesrc
2026-10-03provenance_existence: self-reported → sourced, WEB 2026-10-03provenance_existenceself-reported → sourcedWEB 2026-10-03
2026-09-30provenance_investor_atlas_venture: unknown → sourced, WEB 2026-09-30provenance_investor_atlas_ventureunknown → sourcedWEB 2026-09-30

Records begin 2026-09-24. all_changes